Editors' ChoiceCancer A new hope for neuroblastoma treatment? Joan MonteroInstitute for Bioengineering of Catalonia, Carrer de Baldiri Reixac, 10-12, 08028 Barcelona, Spain. Email: jmontero{at}ibecbarcelona.eu See allHide authors and affiliations Science Translational Medicine 18 Dec 2019:Vol. 11, Issue 523, eaaz9769DOI: 10.1126/scitranslmed.aaz9769 Joan Montero Institute for Bioengineering of Catalonia, Carrer de Baldiri Reixac, 10-12, 08028 Barcelona, Spain. Email: Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: jmontero@ibecbarcelona.eu Article Info & Metrics eLetters Article Information vol. 11 no. 523 DOI: https://doi.org/10.1126/scitranslmed.aaz9769 Published By: American Association for the Advancement of Science Print ISSN: 1946-6234 Online ISSN: 1946-6242 History: . Copyright & Usage: Copyright © 2019, American Association for the Advancement of Science Author Information Joan MonteroInstitute for Bioengineering of Catalonia, Carrer de Baldiri Reixac, 10-12, 08028 Barcelona, Spain. Email: jmontero{at}ibecbarcelona.eu Altmetric Article usage Article lifetimeLast 6 monthsThis monthArticle usage: December 2019 to January 2021 AbstractFullPdf Dec 201925027173 Jan 2020262620 Feb 202012911 Mar 20204940 Apr 202071260 May 20209773 Jun 202031720 Jul 20205610 Aug 20206590 Sep 20206560 Oct 202012620 Nov 20208790 Dec 20205940 Jan 20215370 View Full Text
A new hope for neuroblastoma treatment? By Joan Montero Science Translational Medicine18 Dec 2019 Combined ALK and PIM1 inhibition may treat high-risk neuroblastomas.
A new hope for neuroblastoma treatment? By Joan Montero Science Translational Medicine18 Dec 2019 Combined ALK and PIM1 inhibition may treat high-risk neuroblastomas.